Weight Loss Drugs: FSA Eligibility

Weight loss medications, including GLP-1 receptor agonists, are considered eligible medical expenses because they are prescribed to treat a specific medical condition, such as obesity, Type 2 diabetes, or metabolic syndrome. These medications must be prescribed by a licensed healthcare provider, making them a recognized form of medical treatment. Explore weight loss treatments from licensed providers at FSA Store.

GLP‑1 receptor agonists—such as semaglutide and liraglutide—mimic the natural incretin hormone GLP‑1 to suppress appetite by activating receptors in the hypothalamus, slowing gastric emptying, and reducing food intake. Peripherally, they enhance glucose‑dependent insulin secretion, inhibit glucagon release, and improve glycemic control, while also reducing triglycerides, LDL cholesterol, adipose inflammation, and ectopic fat deposition—thus treating both obesity and metabolic syndrome. Clinical trials have shown that these agents can produce 10–15 % body weight loss and significant cardiometabolic benefits, including lower blood pressure and improved inflammatory markers.

General weight loss programs, including those involving coaching, diet plans, or behavioral counseling—typically require a Letter of Medical Necessity (LMN) from a licensed healthcare provider to qualify. Not all weight loss services or providers are FSA-eligible, and coverage may vary. Please be sure to check with your plan administrator as to what your specific plan will allow.